Jeffrey Ball
Corporate Officer/Principal chez CSL LIMITED
Profil
Jeffrey Alan Ball is currently the Chief Sustainability Officer at CSL Ltd.
Prior to this, he worked as the Vice President of Operations at Aspen Aerogels, Inc. from 2015 to 2019 and as the Vice President of Global Capital Project Management at Genzyme Corp.
from 2008 to 2012.
He received his undergraduate degree from Bucknell University and his graduate degree from Villanova University.
Postes actifs de Jeffrey Ball
| Sociétés | Poste | Début |
|---|---|---|
| CSL LIMITED | Corporate Officer/Principal | 17/08/2023 |
Anciens postes connus de Jeffrey Ball
| Sociétés | Poste | Fin |
|---|---|---|
| ASPEN AEROGELS, INC. | Directeur des opérations | 27/09/2019 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/12/2012 |
Formation de Jeffrey Ball
| Bucknell University | Undergraduate Degree |
| Villanova University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ASPEN AEROGELS, INC. | Process Industries |
| CSL LIMITED | Health Technology |
| Entreprise privées | 1 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
